Virtus Fund Advisers’s Insulet PODD Stock Holding History

Virtus Fund Advisers’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$293K	Buy	4,244 +980	+30%	+$64.3K	﹤0.01%	456
2017 Q3	$180K	Buy	+3,264	New	+$178K	﹤0.01%	375
2014 Q3	–	Sell	-4,728	Closed	-$188K	–	1729
2014 Q2	$188K	Buy	+4,728	New	+$182K	﹤0.01%	993

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Virtus Fund Advisers's PODD Position: Q4 2017 in Review

Virtus Fund Advisers increased its Insulet (PODD) stake by 30% in Q4 2017, buying an estimated $64.3K and bringing the position to 4,244 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

Virtus Fund Advisers first reported a position in PODD in Q2 2014 and has held it in 3 quarters since. 203 funds tracked by Wall St. Rank hold PODD as of Q4 2017.

Virtus Fund Advisers held 4,244 shares of Insulet worth $293K as of Q4 2017.
Virtus Fund Advisers bought 980 Insulet shares in Q4 2017, an estimated $64.3K.
Insulet made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #456 holding.
Virtus Fund Advisers first reported a position in Insulet in Q2 2014 and has held it in 3 quarters since.
203 funds tracked by Wall St. Rank held Insulet as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.